MedPath

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Phase 4
Completed
Conditions
Hyperhidrosis
Registration Number
NCT00168480
Lead Sponsor
Allergan
Brief Summary

This is a three year open-label study in subjects with axillary hyperhidrosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
424
Inclusion Criteria
  • Marked axillary hyperhidrosis
Exclusion Criteria
  • Previous use of botulinum toxin for hyperhidrosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Assessment of axillary sweat productionEvery 4 Months
Secondary Outcome Measures
NameTimeMethod
Patient reported health outcome measures1 Month Post-Treatment Visit

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.